Log In
Print
BCIQ
Print
Print this Print this
 

Extavia, interferon beta-1b

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionInterferon (IFN) beta-1b
Molecular Target Type I interferon (IFN) receptor
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today